SCHEMBL5607567

SCHEMBL5607567

CCCCC(=Cc1ccc(O)cc1)C(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 2/20 0.47
HSD17B3 P37058 7/20 0.43
ALOX5 P09917 2/20 0.39
ABCG2 Q9UNQ0 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ESR1 P03372 2/20 0.37
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
NR1H2 P55055 1/20 0.37
RNASEL Q05823 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PTGES O14684 1/20 0.37
PPARG P37231 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5607384 0.92 MIF (0.43) MIFHSD17B3ABCG2ALDH1A1KDM4E
SCHEMBL5606940 0.85 MIF (0.46) MIFABCG2ALDH1A1KDM4EMEN1
SCHEMBL5606729 0.84 MIF (0.50) MIFHSD17B3ALOX5ABCG2ALDH1A1
SCHEMBL5607413 0.83 MIF (0.49) MIFHSD17B3ALOX5MEN1KMT2A
SCHEMBL5606696 0.82 NR1H4 (0.55) ALOX5KDM4EMEN1KMT2APTGES
SCHEMBL5607546 0.82 ESR1 (0.51) MIFHSD17B3ALOX5ABCG2ALDH1A1
SCHEMBL6062333 0.82 MIF (0.48) MIFHSD17B3ALOX5ABCG2ALDH1A1
SCHEMBL10924807 0.81 MIF (0.49) MIFHSD17B3ALOX5ABCG2ALDH1A1
SCHEMBL5607169 0.79 ALOX5 (0.52) MIFHSD17B3ALOX5ALDH1A1KDM4E
SCHEMBL29741641 0.79 ALOX5 (0.52) MIFHSD17B3ALOX5ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-1687250-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS Takasago International Corporation (JP) 2006-08-09 EP disclosed
WO-2005051882-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids ALDH1A2, ALDH1A3, GRHPR MIF 2713/4885HSD17B3 287/4885ALOX5 751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.